Cargando…
GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer
BACKGROUND: Ovarian cancer (OC) is the deadliest gynecological cancer, often diagnosed at advanced stages. A fast and accurate diagnostic method for early-stage OC is needed. The tumor marker gangliosides, GD2 and GD3, exhibit properties that make them ideal potential diagnostic biomarkers, but they...
Autores principales: | Galan, Alba, Papaluca, Arturo, Nejatie, Ali, Matanes, Emad, Brahimi, Fouad, Tong, Wenyong, Hachim, Ibrahim Yaseen, Yasmeen, Amber, Carmona, Euridice, Klein, Kathleen Oros, Billes, Sonja, Dawod, Ahmed E., Gawande, Prasad, Jeter, Anna Milik, Mes-Masson, Anne-Marie, Greenwood, Celia M. T., Gotlieb, Walter H., Saragovi, H. Uri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145910/ https://www.ncbi.nlm.nih.gov/pubmed/37124505 http://dx.doi.org/10.3389/fonc.2023.1134763 |
Ejemplares similares
-
The cancer glycocode as a family of diagnostic biomarkers, exemplified by tumor-associated gangliosides
por: Nejatie, Ali, et al.
Publicado: (2023) -
Ligands Binding to Cell Surface Ganglioside GD2 Cause Src-Dependent Activation of N-Methyl-D-Aspartate Receptor Signaling and Changes in Cellular Morphology
por: Tong, Wenyong, et al.
Publicado: (2015) -
Expression of GD2 and GD3 gangliosides in human embryonic neural stem cells
por: Yanagisawa, Makoto, et al.
Publicado: (2011) -
Ganglioside GD3 synthase (GD3S), a novel cancer drug target
por: Liu, Jinyi, et al.
Publicado: (2018) -
Acetylation Suppresses the Proapoptotic Activity of GD3 Ganglioside
por: Malisan, Florence, et al.
Publicado: (2002)